Endocrinology
Pancreas Function
Endocrine and exocrine — insulin, glucagon, and digestive enzymes
The pancreas is a dual-function organ — exocrine acini secrete digestive enzymes (~1.5 L/day) into the duodenum via Wirsung and Santorini ducts, while endocrine islets of Langerhans secrete hormones into the bloodstream. Islet cells: β cells (insulin, 70%), α cells (glucagon, 20%), δ cells (somatostatin), PP cells (pancreatic polypeptide), ε cells (ghrelin). Exocrine secretions include amylase, lipase, trypsinogen (activated to trypsin in duodenum), chymotrypsinogen, elastase, and bicarbonate (neutralizes gastric acid). Disease: type 1 diabetes (autoimmune β cell destruction), type 2 diabetes (insulin resistance), pancreatitis (premature trypsin activation), pancreatic adenocarcinoma (90% 5-year mortality).
- Daily secretion~1.5 L pancreatic juice/day
- β cell hormoneInsulin (lowers glucose)
- α cell hormoneGlucagon (raises glucose)
- Key enzymesAmylase, lipase, trypsin, chymotrypsin
- ActivationEnterokinase activates trypsinogen in duodenum
- pH neutralizationBicarbonate from duct cells (CFTR-mediated)
Interactive visualization
Press play, or step through manually. The visualization is yours to drive — try it before reading on.
Watch the 60-second explainer
A condensed visual walkthrough — narrated, captioned, under a minute.
Why pancreas function matters
- Diabetes. 11% of US adults; β cell physiology drives every treatment.
- Acute pancreatitis. 275,000 US admissions/year; rapid recognition is life-saving.
- Cystic fibrosis. Pancreatic insufficiency in 85% requires enzyme replacement.
- Pancreatic cancer. 4th leading cancer death; early detection research is urgent.
- Hypoglycemia. Insulinoma, sulfonylurea overdose, glucagon deficiency.
- Nutrition. Without pancreatic enzymes, fat absorption fails causing malnutrition.
- Drug development. GLP-1 agonists and SGLT2 inhibitors transformed type 2 diabetes care.
Common misconceptions
- Type 1 and type 2 are the same disease. Type 1 is autoimmune β cell destruction; type 2 is insulin resistance plus relative insulin deficiency.
- Lipase and amylase always rise together. Lipase is more specific; amylase rises in salivary disease, ovarian, and renal failure too.
- The pancreas only does insulin. Exocrine function affects every meal — its loss causes severe malnutrition.
- Insulin makes you fat. Insulin promotes anabolism but obesity drives type 2 diabetes — the causality is complex.
- Glucagon only treats hypoglycemia. Also reverses beta-blocker overdose by raising cAMP independently of β receptors.
- All pancreatitis is alcohol-related. Gallstones cause more cases; many idiopathic, drug-induced, or hereditary (PRSS1, SPINK1).
Frequently asked questions
How do β cells sense glucose?
Glucose enters β cells via GLUT2, gets phosphorylated by glucokinase (the rate-limiting glucose sensor), and enters glycolysis. Increased ATP/ADP ratio closes ATP-sensitive K+ channels (KATP), depolarizing the membrane. This opens voltage-gated Ca2+ channels; Ca2+ influx triggers insulin granule exocytosis. Sulfonylureas (glyburide, glipizide) close KATP channels independent of glucose, stimulating insulin release. Used in type 2 diabetes.
Why doesn't the pancreas digest itself?
Multiple safeguards. Enzymes are secreted as inactive zymogens (trypsinogen, chymotrypsinogen, proelastase, prophospholipase). Activation requires duodenal enterokinase converting trypsinogen to trypsin, which then activates other zymogens. Pancreas contains pancreatic secretory trypsin inhibitor (SPINK1) blocking premature activation. Acinar cells maintain low intracellular Ca2+ and have autophagy mechanisms. Failure causes pancreatitis — enzymes auto-digest tissue.
What causes acute pancreatitis?
Gallstones (40%) and alcohol (30%) account for most cases. Other: hypertriglyceridemia (> 1000 mg/dL), hypercalcemia, ERCP, drugs (azathioprine, valproate), trauma, mumps, autoimmune. Mechanism: premature activation of trypsinogen in acinar cells causes auto-digestion, inflammation, and systemic inflammatory response. Diagnosis requires 2 of 3: characteristic pain, lipase > 3x upper limit, imaging findings. Severe pancreatitis: organ failure, necrosis, mortality 15-30%.
How do glucagon and insulin oppose each other?
Insulin (β cells, fed state): promotes glucose uptake (GLUT4 in muscle/fat), glycogen synthesis, lipogenesis, protein synthesis. Glucagon (α cells, fasting): promotes glycogenolysis, gluconeogenesis, ketogenesis, lipolysis. Insulin/glucagon ratio determines net hepatic glucose flux. In type 1 diabetes, both insulin deficiency AND inappropriate glucagon excess contribute to hyperglycemia. Glucagon is also given for severe hypoglycemia and beta-blocker overdose.
What's the role of CFTR in the pancreas?
Pancreatic duct cells secrete bicarbonate-rich fluid via CFTR Cl- channels coupled with Cl-/HCO3- exchangers. In cystic fibrosis, CFTR mutation causes thick, viscous secretions that block ducts, leading to enzyme retention and pancreatic auto-digestion in utero. By birth, ~85% of CF patients have pancreatic insufficiency requiring enzyme replacement (pancrelipase). Eventually, β cells are also lost, causing CF-related diabetes (CFRD) — distinct from type 1 and type 2.
How is pancreatic insufficiency diagnosed and treated?
Symptoms: steatorrhea (fatty stools), weight loss, fat-soluble vitamin deficiency (A, D, E, K). Diagnosis: fecal elastase < 200 μg/g, 72-hour fecal fat > 7 g/day. Causes: chronic pancreatitis, CF, pancreatic cancer, total pancreatectomy. Treatment: pancrelipase (porcine-derived lipase, amylase, protease) with meals, dose by lipase units (25,000-80,000 per meal). Plus fat-soluble vitamin supplementation and PPI to optimize enzyme activity.
Why is pancreatic cancer so deadly?
Pancreatic adenocarcinoma carries 90% 5-year mortality. Reasons: late presentation (vague symptoms — back pain, weight loss, painless jaundice), aggressive biology (KRAS mutation in 90%, dense desmoplastic stroma resists chemotherapy), early metastasis, surgical resection feasible in only 15-20%. Whipple procedure (pancreaticoduodenectomy) is the curative attempt for head tumors. Adjuvant chemotherapy (FOLFIRINOX, gemcitabine-nab-paclitaxel) modestly improves survival.